Imraan Ahmed

Venture Capital

📍 New York, New York, United States🔄 Updated September 2026💼 13 investments📅 13 years investing🗓 Last invested Jan 2020𝕏 @upgrade_to_unlock
VC🌍 United States
13
Total investments
4
Early stage
5
Mid stage
0
Late stage
13y
Years active

Portfolio

10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer & Investor
2020
Ride Health partners with healthcare organizations and transportation providers to manage transportation benefits, strengthen enterprise transportation programs, and drive intelligent transitions of care. We blend technology and data with a human approach to break down access barriers and solve some of the biggest transportation challenges that care coordinators, providers, and payers face. Our platform maps out each patient’s unique needs and preferences for the best ride experience across clinical and social needs, ensuring greater access, improved efficiencies, lower costs, and better outcomes.
Investor
2020
Redesign Health is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh.
Investor, Board Observer
2018
Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.
Board Observer
2018
Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.
Investor
2018
ACV is a high growth technology company that provides a vibrant digital marketplace for wholesale vehicle transactions and data services. ACVs marketplace called ACV Auctions offers transparent and accurate vehicle information to customers powered by technology innovations and data insights. On a mission to build and enable the most trusted and efficient digital marketplaces for buying and selling used vehicles, ACV’s platform leverages data insights and technology to power its digital marketplace and data services, enabling dealers and commercial partners to buy, sell and value vehicles with confidence and efficiency. ACV’s network of brands includes ACV Auctions, ACV Transportation and ACV Capital within its Marketplace Products as well as True360, ACV Data Services and MAX Digital.
Investor
2017
Explorer accelerates device commercialization by synchronizing access to live cases with digital procedural playbooks and intraoperative data capture.
Investor
2017
Maven is the worlds largest virtual clinic for women and families on a mission to make healthcare work for all of us. Mavens award-winning digital programs provide clinical, emotional, and financial support all in one platform, spanning fertility & family building, maternity & newborn care, parenting & pediatrics, and menopause & midlife. More than 2,000 employers and health plans trust Mavens end-to-end platform to improve clinical outcomes, reduce healthcare costs, and provide equity in benefits programs. Recognized for innovation and industry leadership, Maven has been named to the Time 100 Most Influential Companies, CNBC Disruptor 50, Fast Company Most Innovative Companies, and FORTUNE Best Places to Work. Founded in 2014 by CEO Kate Ryder, Maven has raised more than $425 million in funding from top healthcare and technology investors including General Catalyst, Sequoia, Dragoneer Investment Group, Oak HC/FT, StepStone Group, Icon Ventures, and Lux Capital. To learn more about Maven, visit us at mavenclinic.com.
Investor
2017
HENRY is moving healthcare delivery forward, by providing onsite dental care to employees at corporate offices. We work with employers that who care about the wellbeing of their employees. Our in-network team of dental providers come onsite in a high-end, technology enabled mobile practice. There is no cost to companies, and no cost to employees. We're like any other in-network provider, except more convenient and way more flossome. It's a win-win...win. To lean more or to schedule HENRY at your company, email hello@HENRYthedentist.com
Investor
2016
Lift smarter, crush your goals, and #PowerProgress with us. Welcome to the future of fitness. View open roles at www.tonal.com/careers. All official Tonal career communication will come from a @tonal.com email address. If you are ever uncertain of whether a solicitation is from Tonal or an approved recruiting partner of ours, please reach out to careers@tonal.com.
Board Observer
2013
Healthsense, the fastest growing provider of aging services technology, provides technology-enabled care solutions for the entire senior care continuum. With a full range of remote monitoring, emergency response, and wellness management solutions, Healthsense helps senior care providers reduce costs, increase independence, and enhance caregiver and senior experiences. Built on a Wi-Fi platform, Healthsense products are scalable and enable flexible technology-enabled care designs that help communities deliver the highest quality of care.
Experience · 21 entries
All (21)
Investments (13)
Founder (1)
Board (6)
2020
Board Observer & Investor
2020
Ride Health partners with healthcare organizations and transportation providers to manage transportation benefits, strengthen enterprise transportation programs, and drive intelligent transitions of care. We blend technology and data with a human approach to break down access barriers and solve some of the biggest transportation challenges that care coordinators, providers, and payers face. Our platform maps out each patient’s unique needs and preferences for the best ride experience across clinical and social needs, ensuring greater access, improved efficiencies, lower costs, and better outcomes.
Investor
2020
Redesign Health is a global venture and applied technology firm focused on building next-generation healthcare companies. We manage venture capital and venture buyout strategies, each powered by an AI operating system and team of leading technologists, entrepreneurs, and investors. Our venture capital strategy backs exceptional founders at the earliest stage—often before an idea is fully formed—and provides first institutional capital and an unmatched degree of strategic leverage and domain expertise through exit. Our venture buyout strategy partners with proven management teams through control investments and delivers outsized value by rewiring core products and workflows with AI. Since inception in 2018, Redesign and our portfolio companies have touched the lives of more than 15 million patients, raised over $1.5 billion from premier institutional, sovereign, and strategic investors, and built distinctive partnerships with marquee healthcare organizations and senior leaders around the world. Redesign is based in New York and has offices in Bengaluru, Los Angeles, and Riyadh.
2018
Investor, Board Observer
2018
Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.
General Partner
2018
Armory Square Ventures is a venture capital firm based in Upstate New York and NYC. We often provide the first round of institutional capital for companies targeting the largest industries across New York State and select emerging cities across the Northeast. We are actively involved in all aspects of company growth—from recruiting senior talent, customers, and co-investors to providing general management support. We launched our firm in 2014 and consider ourselves fortunate to be backed by the region’s most respected institutions, corporations and foundations. Our entrepreneurs tend to be as passionate as our community is to build companies that support and grow their own towns and geographies.
Board Observer
2018
Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.
Show all 21 entries ↓
Investment activity
2013–2020 · 13 investments
201312015220162201732018320202
Recent (last 2 years)Earlier